Publications by authors named "Miranda Raggio"

Claim this Profile
D
Decisions on Non-oncology Breakthrough Therapy Designation Requests in 2017-2019.
Atasi Poddar, Miranda Raggio, John Concato

Ther Innov Regul Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes?
Elizabeth Richardson, Gregory Daniel, David R Joy, Sandra L Kweder, Diane M Maloney, Miranda J Raggio

Ther Innov Regul Sci· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough Therapy Designation: CDER Analysis of Requests 4 Years Into the Program.
Ryan Conrad, Kimberly Taylor, Miranda Raggio, Afi Harrington, Grace Stark

Ther Innov Regul Sci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors.
Nilofer Azad, Alyssa Perroy, Erin Gardner, Chiyo K Imamura, Cynthia Graves, Miranda Raggio

Cancer Biol Ther· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Mahrukh M Hussain, Herbert Kotz, Lori Minasian, Ahalya Premkumar, Gisele Sarosy, Miranda Raggio

J Clin Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis